Clinical Trial Update: Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating the effects of physical therapy and dalfampridine on functional mobility in non-ambulatory people with multiple sclerosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dalfampridine (dalfampridine)
• physical therapy

Snippet

Sponsor: D'Youville College | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED